Trial Profile
Comparison of safety and efficacy of rivaroxaban and enoxaparin for treatment of venous thromboembolism in cancer patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jun 2017
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary) ; Enoxaparin sodium
- Indications Venous thromboembolism
- Focus Adverse reactions; Therapeutic Use
- 06 Jun 2017 Results presented at the 53rd Annual Meeting of the American Society of Clinical Oncology
- 06 Jun 2017 New trial record